High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and Rs2221903 Polymorphism

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Aug 10

PMID 39124778

Authors

Noemi Espinoza-Garcia

Diana Celeste Salazar-Camarena

Miguel Marin-Rosales

Maria Paulina Reyes-Mata

Maria Guadalupe Ramirez-Duenas

Jose Francisco Munoz-Valle

Itzel Maria Borunda-Calderon

Aaron Gonzalez-Palacios

Claudia Azucena Palafox-Sanchez

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and diverse tissue and organ inflammatory affections. Interleukin 21 (IL-21) is implicated in B cell survival, proliferation, differentiation, class switching, and immunoglobulin production; therefore, it is considered a key cytokine in the pathogenesis of SLE. However, its association with disease activity and clinical phenotypes remains unclear. We aimed to evaluate the association of IL-21 levels with the disease activity and clinical phenotypes in patients with SLE. Also, we analyzed the polymorphisms associated with increased IL-21 levels. : The IL-21 serum levels were determined using the enzyme-linked immunosorbent assay (ELISA) method. The rs2221903 and rs2055979 polymorphisms were assessed in 300 healthy controls (HCs) and 300 patients with SLE by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. The levels of IL-21 were monitored during follow-up visits in 59 patients with SLE. : The patients with SLE showed higher IL-21 levels compared to the HCs. The IL-21 levels did not correlate with Mex-SLEDAI and were not different in patients with inactive, mild-moderate, and severe disease. The IL-21 levels were increased in patients with hematological affection. The ROC curve analysis revealed that the IL-21 levels had good predictive power in discriminating among patients with SLE and HCs. In a follow-up analysis, the levels of IL-21 remained higher in the patients with SLE even when the patients were in remission. Also, the rs2221903 polymorphism was associated with increased IL-21 levels. : This study highlights the importance of IL-21 as a key cytokine in SLE. IL-21 levels are higher in patients with SLE and remain increased regardless of disease activity. According to the ROC analysis, IL-21 is a potential biomarker of SLE. Further longitudinal studies are needed to explore the relationship between IL-21 and the clinical phenotypes of SLE.

References

Robak E, Kulczycka-Siennicka L, Gerlicz Z, Kierstan M, Korycka-Wolowiec A, Sysa-Jedrzejowska A . Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients. Eur Cytokine Netw. 2013; 24(1):60-8. DOI: 10.1684/ecn.2013.0330. View

Feng X, Wang D, Chen J, Lu L, Hua B, Li X . Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One. 2013; 7(12):e51982. PMC: 3524129. DOI: 10.1371/journal.pone.0051982. View

Wang L, Zhao P, Ma L, Shan Y, Jiang Z, Wang J . Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. J Rheumatol. 2014; 41(9):1781-92. DOI: 10.3899/jrheum.131025. View

Shi Y, He L . SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15(2):97-8. DOI: 10.1038/sj.cr.7290272. View

Duarte A, Dantas A, de Ataide Mariz H, Dos Santos F, da Silva J, da Rocha Jr L . Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. Mol Biol Rep. 2013; 40(8):4889-92. DOI: 10.1007/s11033-013-2588-1. View

Sauna Z, Kimchi-Sarfaty C . Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011; 12(10):683-91. DOI: 10.1038/nrg3051. View

Wang N, Gao C, Cui S, Qin Y, Zhang C, Yi P . Induction therapy downregulates the expression of Th17/Tfh cytokines in patients with active lupus nephritis. Am J Clin Exp Immunol. 2018; 7(4):67-75. PMC: 6146154. View

Hirahara S, Katsumata Y, Kawasumi H, Kawaguchi Y, Harigai M . Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity. Lupus. 2020; 29(7):686-696. DOI: 10.1177/0961203320916517. View

Bengtsson A, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H . Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus. 2001; 9(9):664-71. DOI: 10.1191/096120300674499064. View

10.

Guzman J, Cardiel M, Sanchez-Guerrero J, Alarcon-Segovia D . Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol. 1992; 19(10):1551-8. View

11.

Coquet J, Kyparissoudis K, Pellicci D, Besra G, Berzins S, Smyth M . IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol. 2007; 178(5):2827-34. DOI: 10.4049/jimmunol.178.5.2827. View

12.

Long D, Chen Y, Wu H, Zhao M, Lu Q . Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019; 99:1-14. DOI: 10.1016/j.jaut.2019.01.013. View

13.

Sun Z, Zhang R, Wang H, Jiang P, Zhang J, Zhang M . Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells. J Biomed Res. 2013; 26(6):456-66. PMC: 3597043. DOI: 10.7555/JBR.26.20120115. View

14.

Li Y, Rauniyar V, Yin W, Hu B, Ouyang S, Xiao B . Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis. Neurol Sci. 2013; 35(1):29-34. DOI: 10.1007/s10072-013-1460-3. View

15.

Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z . A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009; 19(4):519-23. DOI: 10.1038/cr.2009.33. View

16.

Lee J, Shin E, Lee S, Her Y, Park M, Kwok S . Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus. Immunology. 2014; 142(4):573-80. PMC: 4107667. DOI: 10.1111/imm.12263. View

17.

Ding L, Wang S, Chen G, Leng R, Pan H, Ye D . A single nucleotide polymorphism of IL-21 gene is associated with systemic lupus erythematosus in a Chinese population. Inflammation. 2012; 35(6):1781-5. DOI: 10.1007/s10753-012-9497-7. View

18.

Shen C, Xue X, Zhang X, Wu L, Duan X, Su C . Dexamethasone reduces autoantibody levels in MRL/lpr mice by inhibiting Tfh cell responses. J Cell Mol Med. 2021; 25(17):8329-8337. PMC: 8419171. DOI: 10.1111/jcmm.16785. View

19.

Herber D, Brown T, Liang S, Young D, Collins M, Dunussi-Joannopoulos K . IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol. 2007; 178(6):3822-30. DOI: 10.4049/jimmunol.178.6.3822. View

20.

Carreno-Saavedra N, Reyes-Perez I, Machado-Sulbaran A, Martinez-Bonilla G, Ramirez-Duenas M, Munoz-Valle J . IL-21 (rs2055979 and rs2221903)/ (rs3093301) Polymorphism and High Levels of IL-21 Are Associated with Rheumatoid Arthritis in Mexican Patients. Genes (Basel). 2023; 14(4). PMC: 10137781. DOI: 10.3390/genes14040878. View